Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
Assessing how drugs affect the CNS is becoming an increasing concern, particularly for road safety. In January 2015, the FDA issued the Draft Guidance – Evaluating Drug Effects on the Ability to Operate a Motor Vehicle. 2 years later, where are we now?
James Coffman responds to questions from our recent webinar, ‘How chronic stress experienced during early development epigenetically programs adult disease risk’.
Emery Brown discusses how general anesthesia can be used to understand and develop new treatments for neurological conditions, and looks ahead at the future of the field.
In this edition of NCTalks, we speak to Robyn Klein as part of our Spotlight on neuroimmunology – Robyn discusses her research, how inflammatory processes contribute to neurologic disease, and whether immunology and inflammation could be the basis of an eventual preventative treatment for neurodegenerative disease.
Lauren Pulling speaks to Bart De Strooper about his role as the Director of the new UK Dementia Research Institute and his vision for this exciting new venture.
The latest update on the potential accumulation of gadolinium in brain tissue from gadolinium-based contrast agents
Epidemiological studies have shown that chronic stress experienced very early in life—even prenatally—increases the risk of developing inflammatory disease in adulthood, including mental health disorders such as anxiety and depression.
As part of our focus on women in STEM for International Women’s Day 2017 #BeBoldForChange, we have collated some of the top content across the Future Science Group digital sites.
Editor Lauren Pulling speaks to Helen Ling, lead author on a recent pathological study that found evidence of CTE pathology in the brains of retired soccer players